{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:43Z","timestamp":1759333183341},"reference-count":29,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T00:00:00Z","timestamp":1106870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Bronchial asthma is characterized by airway inflammation, notably because of eosinophils and T cells. Thymus and activation\u2010regulated chemokine (TARC) is known to selectively attract Th2 cells, and is increased in response to interleukin (IL)\u20104 and IL\u201013, which share a common receptor, IL\u20104 receptor alpha (IL\u20104R<jats:italic>\u03b1<\/jats:italic>). While corticosteroids have proven, very effective in modifying airway inflammation, the effect of corticosteroids on TARC in asthmatics has been little studied.<\/jats:p><jats:p><jats:bold>Objective:\u2002<\/jats:bold> We examined the effects of inhaled budesonide (BUD) on the expression of TARC and the number of inflammatory cells in bronchial biopsy specimens taken from asthma patients.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Inhaled BUD 800\u2003<jats:italic>\u03bc<\/jats:italic>g daily, or placebo was administered for 3\u2003months in a double\u2010blind, parallel\u2010group study, and bronchial biopsies were performed before and after treatment. Biopsy specimens were examined by immunocytochemistry.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> We observed a significant decrease in the epithelial expression of TARC (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) in the BUD group compared with the placebo group. This was accompanied by decreases in the number of eosinophils (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01), CD3<jats:sup>+<\/jats:sup> T cells (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), and CD4<jats:sup>+<\/jats:sup> T cells (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01). A significant correlation was found between changes in epithelial TARC and in IL\u20104R<jats:italic>\u03b1<\/jats:italic> immunoreactivity (<jats:italic>r<\/jats:italic><jats:sub>s<\/jats:sub>\u2003=\u20030.66, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> These findings suggest that corticosteroid asthma treatment can reduce infiltration of the airway by inflammatory cells, an effect modulated by down\u2010regulation of bronchial epithelial TARC expression.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2005.00694.x","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T10:01:29Z","timestamp":1106992889000},"page":"317-322","source":"Crossref","is-referenced-by-count":12,"title":["Effect of inhaled corticosteroid on an immunoreactive thymus and activation\u2010regulated chemokine expression in the bronchial biopsies from asthmatics"],"prefix":"10.1111","volume":"60","author":[{"given":"M.","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,28]]},"reference":[{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.5.9903102"},{"key":"e_1_2_13_3_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.169"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.23.15036"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.3.1764"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.1.129"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.6.875"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.4.2205"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2001.01152.x"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(99)01492-9"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70029-6"},{"key":"e_1_2_13_12_2","volume-title":"National Asthma Education and Prevention Program: guideline for the diagnosis and management of asthma","author":"National Institute of Health","year":"1997"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.80.5.600"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/32.2.6198355"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-8981(02)00131-6"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70379-9"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.1n3503.x"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2002.1s3256.x"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00083303"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.113237"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.2055"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.126378"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.126079"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90272-0"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.153.2.8564096"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.155.3.9117015"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70529-4"},{"key":"e_1_2_13_28_2","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.163.12.6876","article-title":"Activation of eotaxin gene transcription by NF\u2010kappa B and STAT6 in human airway epithelial cells","volume":"163","author":"Matsukura S","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.5.9706116"},{"key":"e_1_2_13_30_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.119554"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2005.00694.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2005.00694.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T05:27:05Z","timestamp":1696915625000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2005.00694.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,28]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1398-9995.2005.00694.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2005.00694.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,28]]}}}